Record Information |
---|
Version | 2.0 |
---|
Created at | 2020-10-21 16:37:13 UTC |
---|
Updated at | 2021-07-15 16:45:15 UTC |
---|
NP-MRD ID | NP0001777 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | CC-1065 |
---|
Provided By | NPAtlas |
---|
Description | Antibiotic CC 1065 belongs to the class of organic compounds known as pyrroloindoles. Pyrroloindoles are compounds containing a pyrroloindole moiety, which is a tricyclic heterocycle which consists of a pyrrole ring fused to an indole. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Indole is a bicyclic compound consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. CC-1065 is found in Streptomyces and Streptomyces zelensis. CC-1065 was first documented in 1978 (PMID: 104946). Based on a literature review a significant number of articles have been published on Antibiotic CC 1065 (PMID: 30018376) (PMID: 19697908) (PMID: 19660031) (PMID: 17455190) (PMID: 15170593) (PMID: 12226100). |
---|
Structure | [H]OC1=C(OC([H])([H])[H])C2=C(C([H])=C(N2[H])C(=O)N2C3=C(C4=C(N([H])C(=C4[H])C(=O)N4C5=C([H])C(=O)C6=C(C(=C([H])N6[H])C([H])([H])[H])[C@]55C([H])([H])[C@]5([H])C4([H])[H])C(OC([H])([H])[H])=C3O[H])C([H])([H])C2([H])[H])C2=C1N(C(=O)N([H])[H])C([H])([H])C2([H])[H] InChI=1S/C37H33N7O8/c1-14-12-39-27-22(45)10-23-37(24(14)27)11-15(37)13-44(23)35(49)21-9-18-16-4-6-42(28(16)30(46)32(51-2)25(18)41-21)34(48)20-8-19-17-5-7-43(36(38)50)29(17)31(47)33(52-3)26(19)40-20/h8-10,12,15,39-41,46-47H,4-7,11,13H2,1-3H3,(H2,38,50)/t15-,37+/m1/s1 |
---|
Synonyms | Value | Source |
---|
Benzo(1,2-b:4,3-b')dipyrrole-3(2H)-carboxamide, 7-((1,6-dihydro-4-hydroxy-5-methoxy-7-((4,5,8,8a-tetrahydro-7-methyl-4-oxocyclopropa(c)pyrrolo(3,2-e)indol-2(1H)-yl)carbonyl)benzo(1,2-b:4,3-b')dipyrrol-3(2H)-yl)carbonyl)-1,6-dihydro-4-hydroxy-5-methox | HMDB | 4-Hydroxy-7-(4-hydroxy-5-methoxy-7-{3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0,.0,]trideca-2(6),3,8-triene-10-carbonyl}-1H,2H,3H,6H-pyrrolo[3,2-e]indole-3-carbonyl)-5-methoxy-1H,2H,3H,6H-pyrrolo[3,2-e]indole-3-carboximidate | Generator |
|
---|
Chemical Formula | C37H33N7O8 |
---|
Average Mass | 703.7120 Da |
---|
Monoisotopic Mass | 703.23906 Da |
---|
IUPAC Name | 4-hydroxy-7-{4-hydroxy-5-methoxy-7-[(1R,12S)-3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0^{1,12}.0^{2,6}]trideca-2(6),3,8-triene-10-carbonyl]-1H,2H,3H,6H-pyrrolo[3,2-e]indole-3-carbonyl}-5-methoxy-1H,2H,3H,6H-pyrrolo[3,2-e]indole-3-carboxamide |
---|
Traditional Name | 4-hydroxy-7-{4-hydroxy-5-methoxy-7-[(1R,12S)-3-methyl-7-oxo-5,10-diazatetracyclo[7.4.0.0^{1,12}.0^{2,6}]trideca-2(6),3,8-triene-10-carbonyl]-1H,2H,6H-pyrrolo[3,2-e]indole-3-carbonyl}-5-methoxy-1H,2H,6H-pyrrolo[3,2-e]indole-3-carboxamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C2NC(=CC2=C2CCN(C(N)=O)C2=C1O)C(=O)N1CCC2=C3C=C(NC3=C(OC)C(O)=C12)C(=O)N1CC2CC22C1=CC(=O)C1=C2C(C)=CN1 |
---|
InChI Identifier | InChI=1S/C37H33N7O8/c1-14-12-39-27-22(45)10-23-37(24(14)27)11-15(37)13-44(23)35(49)21-9-18-16-4-6-42(28(16)30(46)32(51-2)25(18)41-21)34(48)20-8-19-17-5-7-43(36(38)50)29(17)31(47)33(52-3)26(19)40-20/h8-10,12,15,39-41,46-47H,4-7,11,13H2,1-3H3,(H2,38,50) |
---|
InChI Key | UOWVMDUEMSNCAV-UHFFFAOYSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Species Where Detected | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrroloindoles. Pyrroloindoles are compounds containing a pyrroloindole moiety, which is a tricyclic heterocycle which consists of a pyrrole ring fused to an indole. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Indole is a bicyclic compound consisting of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Indoles and derivatives |
---|
Sub Class | Pyrroloindoles |
---|
Direct Parent | Pyrroloindoles |
---|
Alternative Parents | |
---|
Substituents | - Indolecarboxamide derivative
- Indolecarboxylic acid derivative
- Pyrroloindole
- Hydroxyindole
- Indole
- N-acyl-piperidine
- Anisole
- 2-heteroaryl carboxamide
- N-acylpyrrolidine
- Pyrrole-2-carboxamide
- Pyrrole-2-carboxylic acid or derivatives
- Aryl ketone
- Alkyl aryl ether
- Substituted pyrrole
- Piperidine
- Benzenoid
- Tertiary carboxylic acid amide
- Heteroaromatic compound
- Pyrrolidine
- Pyrrole
- Vinylogous amide
- Urea
- Carboxamide group
- Carbonic acid derivative
- Ketone
- Azacycle
- Carboxylic acid derivative
- Ether
- Organic nitrogen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Carbonyl group
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Hanka LJ, Dietz A, Gerpheide SA, Kuentzel SL, Martin DG: CC-1065 (NSC-298223), a new antitumor antibiotic. Production, in vitro biological activity, microbiological assays and taxonomy of the producing microorganism. J Antibiot (Tokyo). 1978 Dec;31(12):1211-7. doi: 10.7164/antibiotics.31.1211. [PubMed:104946 ]
- Jin WB, Wu S, Jian XH, Yuan H, Tang GL: A radical S-adenosyl-L-methionine enzyme and a methyltransferase catalyze cyclopropane formation in natural product biosynthesis. Nat Commun. 2018 Jul 17;9(1):2771. doi: 10.1038/s41467-018-05217-1. [PubMed:30018376 ]
- Tietze LF, Krewer B, Major F, Schuberth I: CD-spectroscopy as a powerful tool for investigating the mode of action of unmodified drugs in live cells. J Am Chem Soc. 2009 Sep 16;131(36):13031-6. doi: 10.1021/ja902767f. [PubMed:19697908 ]
- Tietze LF, Krewer B: Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies. Chem Biol Drug Des. 2009 Sep;74(3):205-11. doi: 10.1111/j.1747-0285.2009.00856.x. Epub 2009 Jul 29. [PubMed:19660031 ]
- Tietze LF, Major F, Schuberth I, Spiegl DA, Krewer B, Maksimenka K, Bringmann G, Magull J: Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins. Chemistry. 2007;13(16):4396-409. doi: 10.1002/chem.200700113. [PubMed:17455190 ]
- Baraldi PG, Bovero A, Fruttarolo F, Preti D, Tabrizi MA, Pavani MG, Romagnoli R: DNA minor groove binders as potential antitumor and antimicrobial agents. Med Res Rev. 2004 Jul;24(4):475-528. doi: 10.1002/med.20000. [PubMed:15170593 ]
- Kiakos K, Howard TT, Lee M, Hartley JA, McHugh PJ: Saccharomyces cerevisiae RAD5 influences the excision repair of DNA minor groove adducts. J Biol Chem. 2002 Nov 15;277(46):44576-81. doi: 10.1074/jbc.M208169200. Epub 2002 Sep 10. [PubMed:12226100 ]
- Tietze LF, Herzig T, Fecher A, Haunert F, Schuberth I: Highly selective glycosylated prodrugs of cytostatic CC-1065 analogues for antibody-directed enzyme tumor therapy. Chembiochem. 2001 Oct 1;2(10):758-65. doi: 10.1002/1439-7633(20011001)2:10<758::AID-CBIC758>3.0.CO;2-G. [PubMed:11948858 ]
- Park HJ: Evidence for a common molecular basis for sequence recognition of N3-guanine and N3-adenine DNA adducts involving the covalent bonding reaction of (+)-CC-1065. Arch Pharm Res. 2002 Feb;25(1):11-24. doi: 10.1007/BF02975255. [PubMed:11885687 ]
|
---|